NC
Neurocompute
AI-powered research intelligence
 Partner With Us →
Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 39,937 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

Explore Platform → See latest papers
39,937 Papers indexed
1,440 Papers AI scored
39,937 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.
LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
LATEST PEDIATRIC CANCER PAPERS

Database feed

Last ingest 2026-11-01 10:15 AM
1 Genetic Testing Station Provides Increased Access to Germline Genetic Testing for Pediatric Oncology Patients. Journal of genetic counseling — Nov 01, 2026 2 Pediatric and Adolescent Cancers Among American Indian and Alaska Native Peoples. Pediatrics — Nov 01, 2026 3 Comment on "Understanding the Immune Response Changes to Clinical Interventions for Epstein-Barr Virus Infection Prior to Lymphoma Development in Children After Organ Transplants (UNEARTH)". Pediatric transplantation — Nov 01, 2026 4 Predicting for Malignancy in Congenital Lung Malformations: A Single-Center Study of the "At Risk" Pediatric and Adult Population. Thoracic cancer — Nov 01, 2026 5 Dental abnormalities as long-term effects in pediatric patients with leukemia: A scoping review. Medicina oral, patologia oral y cirugia bucal — Nov 01, 2026 6 Quality Indicators in End-of-Life Care for Children With Cancer in Low- and Middle-Income Countries. Cancer medicine — Nov 01, 2026 7 Azole-Resistant Aspergillosis: An Emerging Diagnostic and Therapeutic Challenge in Paediatrics. Mycoses — Nov 01, 2026 8 Increased Healthcare Utilization and Differential Outcomes for Pediatric Cancer Versus Non-Cancer Patients. Cancer medicine — Nov 01, 2026
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

39937 results
C
A Novel FLI1 Monoclonal Antibody Which Recognizes EWS::FLI1 with High Affinity Is Useful for Detecting Ewing Sarcoma.
PMID 41283512 Published: 2025-11-10 Ingested: 2026-08-02 12:05 AM Antibodies (Basel, Switzerland)
AI -
Standard 58.16
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 58.2/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 20.8; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Psychiatric features in NMDAR and LGI1 antibody-associated autoimmune encephalitis.
PMID 37029805 Published: 2023-04-08 Ingested: 2026-08-02 12:02 AM European archives of psychiatry and clinical neuroscience
AI -
Standard 58.16
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 58.2/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 20.8; sample size: 40.0; recency: 65.0; abstract quality: 100.0.

C
General anaesthetics reduce acute lymphoblastic leukaemia malignancies in vitro and in vivo via CXCR4 and osteopontin mediated mechanisms.
PMID 38798305 Published: 2025-10-09 Ingested: 2026-08-02 12:05 AM F1000Research
AI -
Standard 58.15
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 58.2/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 50.8; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

C
Preclinical assessment of checkpoint blockade combined with DNA methyltransferase inhibition in high-risk pediatric brain tumors reveals limited therapeutic synergy.
PMID 41541220 Published: 2025-11-13 Ingested: 2026-08-02 12:05 AM Neuro-oncology advances
AI -
Standard 58.14
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 58.1/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 58.2; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Albacarcin V adds EPLIN as a novel and promising target for the treatment of female cancers and pediatric medulloblastoma.
PMID 41360228 Published: 2025-12-06 Ingested: 2026-08-02 12:05 AM Biochemical pharmacology
AI -
Standard 58.14
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 58.1/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 58.2; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Multi-transcriptomics analysis of ferroptosis related genes reveals CAFs exosomal COX4I2 as a novel therapeutic target in osteosarcoma.
PMID 40977891 Published: 2025-09-04 Ingested: 2026-08-02 12:03 AM Frontiers in cell and developmental biology
AI -
Standard 58.14
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 58.1/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 58.2; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

C
Age-linked DNA methylation and gene expression patterns in parameningeal head and neck alveolar rhabdomyosarcoma reveal CDK9 as a promising therapeutic target.
PMID 40350107 Published: 2025-05-09 Ingested: 2026-08-02 12:04 AM Pharmacological research
AI -
Standard 58.14
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 58.1/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 63.2; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

C
Developmental Oncology: Principles and Therapy of Cancers of Children and Young Adults.
PMID 40097191 Published: 2026-07-01 Ingested: 2026-08-02 12:07 AM Cold Spring Harbor perspectives in medicine
AI -
Standard 58.14
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 58.1/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 43.2; sample size: 20.0; recency: 100.0; abstract quality: 40.0.

C
Secondary ovarian germ cell tumor following Wilms tumor after eight years post-treatment: A rare case report.
PMID 40037278 Published: 2025-03-03 Ingested: 2026-08-02 12:04 AM International journal of surgery case reports
AI -
Standard 58.14
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 58.1/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 68.2; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

C
Alveolar Rhabdomyosarcoma of Nasopharynx and Paranasal Sinuses in Children Diagnosis and Treatment-Review of the Literature and Case Report.
PMID 39859062 Published: 2025-01-06 Ingested: 2026-08-02 12:03 AM Medicina (Kaunas, Lithuania)
AI -
Standard 58.14
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 58.1/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 68.2; sample size: 20.0; recency: 90.0; abstract quality: 85.0.

C
Incidence, characteristics, and survival in early- and late-onset colorectal cancer.
PMID 40734574 Published: 2025-07-30 Ingested: 2026-08-02 12:12 AM Acta oncologica (Stockholm, Sweden)
AI -
Standard 58.12
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 58.1/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 18.1; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

C
Early-life human CD8+ T cells exhibit rapid, short-lived effector responses and a unique transcription factor landscape.
PMID 40720649 Published: 2025-07-28 Ingested: 2026-08-02 12:04 AM Proceedings of the National Academy of Sciences of the United States of America
AI -
Standard 58.12
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 58.1/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 18.1; sample size: 20.0; recency: 90.0; abstract quality: 100.0.

Previous
Page 2153 of 3329
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.
Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic